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Introduction 
 Mucolipidosis II (MIM 252500) also known as I cell disease and MLIIIA (MIM 252600) are rare lysosomal    
storage disorders caused by absent or diminished GlcNAc-phosphotransferase activity respectively. The        
resulting defective mannose phosphorylation affects transport of lysosomal hydrolases into the lysosome.   
Severe mutations in both alleles of GNPTAB encoding α and β subunits of GlcNAc-phosphotransferase result 
in MLII and MLIIA and heterozygous missense mutations are associated with familial persistent stuttering.  
 Mucolipidosis III gamma (MIM #252605) is a very rare variant affecting 1 in 1-4,00000 individuals. Mutations 
in GNPTG gene that cause mucolipidosis IIIγ disrupt the tagging of digestive enzymes with mannose 6      
phosphate (M6P), which prevents many enzymes from reaching the lysosomes.  
 In this report, we describe clinical details from 9 cases from one Indian centre with mucolipidois II and III,     
including a sib pair with Type III γ with a novel homozygous mutation 
Table 1: Clinical profile and laboratory investigations in 9 patients with  
Mucolipidosis II and III 
Patient 
Name 
1 Po 
  
2 Ak 
  
3 Tr 
  
4 Ya 
  
5 Sr 
  
6 Na 
  
7 Ch 
  
8 Sri 
  
9 Cha 
  
  
Present age 
15m Died 
2y11m 
Died 
1y11m 
Died 
4y9m 
4 ½ y 3y2m 8 ½ y 5 ½ y 12y8m 
Sex M/F 
  
F M M F M F F M F 
Age at diagnosis 
  
9m 17m 16m 20m 3y 15m 7y 4y 5 ½ y 
Parental consan-
guinity 
Y/ FC Y/UN N N Y, UN Y/FC Y/FC Y/ FC Y/ FC 
Other affected 
family member 
N N N N N N Y Y N 
Birth weight 
(kgs) 
2.25 
C/S 
2.19 
C/S 
2.2 
C/S 
2.45 <2 2.25 Home 
del 
2.2 2 
Coarse face 
  
Y Y 
4-6m 
Y 
5m 
Y Y++ Y Mild Mild Y 
Wt at 
Diagnosis (kgs) 
5 6.9 5.5 6.25 7.2 6.2 14.5 12.5 9 
OFC (cms) 
  
38 43.5 43.5 43 44.5 41 52 51 42.5 
Craniosynostosis 
  
N N N Y Y N Y Y Y 
GDD 
  
+ ++ ++ ++ Mod Mod ++ + N Mod 
Eyes 
  
Cloudy cor-
nea 
Blepharitis 
Cloudy cor-
nea 
Ocular albi-
nism 
Cloudy cor-
nea 
Fundus N 
Mild 
V alt esot-
ropia Fun-
dus N 
Cloudy 
cornea, 
temporal 
pallor 
N Early cloud-
ing 
N Mild cloud-
ing 
Gum hypertrophy Mild, no 
dentition 
Y, no denti-
tion 
Y, no denti-
tion 
Y, No denti-
tion till 4y 
Y Y, no den-
tition 
Y N Y/ dental 
caries 
Hirsutism 
  
Y Y Y Y Y Y N N Mild 
Respiratory 
problems 
Stridor Low O2 sats 
Rec LRI 
Rec LRI Rec 
LRI 
Y, stridor 
LRI 
Y Y N N 
CVS 
  
PFO N Mod MR, 
AML 
prolapse 
N 22m MR+ Cardiac 
murmur 
MR+ N MR ++, AR 
Hands 
  
Clawed 
NCV N 
Clawed 
NCV N 
Clawed , bi-
lat SPC 
Clawed 
No CTS 
Clawed Clawed +++ 
CTS 
+++ 
CTS 
+++ from 
age 8y 
CTS 
USG abdomen 
  
N N N N N N N N Mild hepa-
tomegaly 
Skeletal survey 
  
Typical Typical Typical Mild 6m Typical Typical Mod Mod Typical, os-
teoporosis 
  
MRI brain 
  
Micro-
cephaly, 
N brain 
No Dilated lat 
ventricles 
CT N No No No No Cranio-
synostosis 
Plasma Enzyme 
estimation 
              Not done   
Alpha mannosi-
dase 
100X 40X 10X 40X 40X 44X 4X   4X 
Alpha Fucosidase 
  
10X 3.4X 96X 10X 5X 5X 3X   9X 
Beta hexosamini-
dase Total 
5X 3X 9X 6X 5X 4X 3X   11X 
Others 
  
  
OCT  N Died 2y11m 
Resp inf 
  
5m: R      
inguinal 
hernia      
repair 
  
R inguinal 
hernia 
Lost FU 
Bilat ingui-
nal herniae 
Lost to FU Sx for CTS Sx for 
CTS 
Sx for CTS 
Papules on 
lip mucosa 
Mutation 
studies 
c.3503_35
04delTC 
(exon 19)  
c.3335+1G
>A hom, 
Ex 17 
Declined 
test 
Compd 
hetero. 
Ex 17 & 
Ex19 
  
Not done c.3503_35
04delTC 
(exon 19)  
c.512insG
TGG (exon 
7) 
c.512insG
TGG 
(exon 
7); p.H17
2WfsX28 
Awaited 
FC: first cousin, UN: uncle niece, MR: mitral regurgitation, CTS: carpal tunnel syndrome, LRI: lower respiratory infection, OTC: optical coherence tomography 
Case 4: Age - 7m                            4y 
 Case 2: Age- 3m                                    2y6m 
 
Case1: 13m 
 
Case 3: 1y6m Case 5: 3y4m Case 6: 3y 
Sib pair with novel homozygous mutation c.512insGTGG (exon 7); p.H172WfsX28 
 
Face in Mucolipidosis Type III  Type III γ  
Type III α/ β  
Above image shows papillary lesions on mucosa Dentition: gum hypertrophy and dental caries in 
MLII, near normal in MLIII  
MLII 
Dystosis multiplex in MLI (I cell disease) age 12m  
Radiology Description 
 Skull that is relatively normal; widened sella turcica.   
 Ribs widened at the costochondral junctions and narrower in the dorsal    
juxta-vertebral parts.  
 Hand X-ray showing abducted thumb with diaphyseal widening and expansion 
of tubular bones. Osteopenia and bullet shaped metacarpals and phalanges. 
Delayed epiphyseal ossification.   
 Rounded vertebral bodies with shortened antero-posterior diameter and     
antero-superior hypoplasia, mainly in the lower thoraco-lumbar vertebrae.  
 Pelvic dysplasia with narrow basilar portions of the ilia and relatively long   
pubic and ischial bones, slanting acetabular roofs with coxa valga. 
 Dysmorphic features, radiological and biochemical studies and mutation spectrum in nine cases             
(5 females and 4males) of MLII and III from one centre studied over a 6yr period are described here.   
Parental consanguinity was present in 6/8 (75%) families and two affected sibs were from one family. 
Age at diagnosis ranged from 5m to 5½ y. Perinatal skeletal abnormalities were described in two.  
 Birth weight at term was < 2.5kgs in all. Growth was below the 3rd centile for all parameters with         
negligible increase beyond 2yrs age. Global developmental delay was seen in all with major motor and 
milder intellectual disabilities. Respiratory problems were present in 7/9 ranging from snoring, stridor 
and recurrent infections to progressive respiratory failure and three died of severe respiratory failure 
aged between 2y and 4y9m.  
 Facial features present universally included coarse face, periorbital fullness, epicanthic folds, flat nasal 
bridge, triangular nasal tip, full lips, delayed or abnormal dentition and gingival hypertrophy. Progressive 
clawing of hands with restricted movements was seen in all nine. Three older children (6½ y, 8y and 
12y8m) had a milder phenotype and all of these had craniosynotosis and bilateral carpal tunnel          
syndrome.  
 Inguinal herniae, light coloured hair and irides and multiple mongoloid patches were seen in two patients 
each. One had persistent papular lesions on lip mucosa, not previously described.  
 Full skeletal survey was done in all with typical dysostosis multiplex and osteopenia.  
 Plasma enzymes (α Mannosidase, α Fucosidase and β Hexosaminidase) were elevated 3 to 40 fold in all 
tested.  
 Echocardiography was abnormal in 6/8 with mitral regurgitation being the commonest defect.  
 Corneal clouding was seen in 6/9 with ocular albinism (1), temporal pallor (1) and normal fundus in 7/9.  
 Abnormal neuro-imaging was noted in 2/5 cases.   
 Results of GNPTAB and GNPTG gene sequencing are available in six cases. Recurrent common mutations 
in Exons 17 and 19 of GNPTAB gene were noted in cases 1, 2, 4 and 6 (Table 1). A novel homozygous    
insertion was seen in Exon 7 of GNPTG gene in cases 7 and 8 (both sibs). Functional studies to further       
delineate this novel mutation have been planned. 
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